RNU6-329P

Across TCGA pan-cancer cohorts, RNU6-329P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-329P data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RNU6-329P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-329P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

UCEC, KIRC, and STAD are the cancer types where RNU6-329P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	II,III,IV	0.198	0.768	.002	108	view →
KIRC	OS	Tertile	All	0.127	0.881	<.001	84	view →
STAD	OS	Tertile	All	0.239	0.739	<.001	45	view →
KIRP	OS	Tertile	All	0.216	0.904	<.001	45	view →
LAML	DFS	Tertile	All	0.206	0.584	.005	36	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	27	view →
SKCM	OS	Tertile	III,IV	0.175	0.705	.001	18	view →
ESCA	DFS	Tertile	III,IV	1.000	0.280	.042	12	view →
LGG	DFS	Tertile	All	0.068	0.826	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-329P–UCEC (OS)

Open the UCEC breakdown →